Commercial Strategy

Increasing Reach Through Distribution Strategies

2 min read
Share

Distribution strategy is one of the most capital-efficient paths to commercial growth available to a mid-market life sciences company — and one of the most systematically underplanned. The appeal is straightforward: access to an established sales infrastructure, immediate geographic reach, and market presence without the fixed cost of direct headcount. The execution complexity is equally...

Distribution strategy is one of the most capital-efficient paths to commercial growth available to a mid-market life sciences company — and one of the most systematically underplanned. The appeal is straightforward: access to an established sales infrastructure, immediate geographic reach, and market presence without the fixed cost of direct headcount. The execution complexity is equally straightforward and consistently underestimated.

The Economic Logic

A direct sales model carries high fixed costs in exchange for high control over the customer relationship and the commercial narrative. A distribution model converts those fixed costs into variable costs — margin points shared with the partner — in exchange for reach that would take years and significant capital to build organically.

The economic argument for distribution is compelling particularly at three moments: early commercial stage, when revenue is insufficient to support a full direct infrastructure; geographic expansion into new markets; and product categories where the transaction is relatively straightforward and does not require deep technical selling.

What Distribution Partners Actually Provide

What Partners Provide

What Partners Cannot Provide

Existing customer relationships

Your positioning and narrative

Geographic coverage

Deep technical selling capability (in most cases)

Local market knowledge

Accountability for your commercial strategy

Transactional sales infrastructure

The reference customers and evidence base you need to grow

Reduced fixed cost burden

Customer ownership — that remains contested

The single most common distribution strategy failure in life sciences is treating partners as a substitute for commercial strategy rather than an extension of it. Partners carry your product. They do not carry your story — unless you have built the messaging, trained the team, and created the tools that make it possible for them to do so.

The Channel Conflict Question

Every distribution strategy eventually confronts channel conflict — the tension between partner relationships and direct customer relationships over who owns the account, who gets the commission, and who controls the narrative. The organizations that manage this well resolve these questions before they become disputes: clear territory definitions, explicit account ownership rules, transparent pricing and margin structures.

When Distribution Strategy Works

Distribution delivers its full potential when four conditions are met: the product is defined clearly enough for a partner to sell it, the partner has genuine access to the target buyer, the margin economics support the partner’s investment in the product, and the organization has built the commercial infrastructure — training, tools, content, technical support — to make the partner successful.